Inside a cancer center's strategic growth and research-driven outreach. Discover how expanded services and partnerships aim to improve access and care.
Key Takeaways
- Institute treated 15,754 new cancer cases in FY2025
- Between 2020 and October 2025 the center opened 609 clinical trials
- Center was the first worldwide to offer the FDA-approved TheraBionic P-1 liver cancer therapy